Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

19 Jan 2012 07:00

RNS Number : 8017V
Xaar PLC
19 January 2012
 



 

 

 

FOR IMMEDIATE RELEASE

19 January 2012

 

 

 

Xaar plc

 

 

YEAR END TRADING UPDATE

 

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the inkjet printing technology group headquartered in Cambridge, announces an update on trading for the year ended 31 December 2011.

 

Trading for the fourth quarter of the year was slightly ahead of the Board's expectations, leading to a strong performance for the full year 2011.

 

Xaar expects to announce revenue of approximately £69 million for 2011, an increase of over 25% compared to 2010 (£54.7 million).

 

Revenue growth in 2011 was achieved mainly by increased sales into the industrial segment. Demand for Xaar's technology in this segment is principally driven by the conversion of ceramic tile printing to digital inkjet from analogue processes. During the year, Xaar made good progress with the capacity expansion programme to support this demand and the programme remains on track to continue to deliver the planned incremental capacity during the first half of 2012.

 

As expected, product sales into the graphic arts segment declined in 2011 by approximately 15% compared to 2010. As previously described, this decline reflects market maturity and competitive pressure.

 

The Group continues to maintain a strong balance sheet with net cash at 31 December 2011 of £17.4 million (30 June 2011 - £20.6 million; 31 December 2010 - £22.0 million).

 

The detailed results for 2011 are expected to be announced on 20 March 2012.

 

Board changes

 

As previously announced Phil Eaves, Sales and Marketing Director, informed the Company in 2011 of his intention to retire from full time employment in June 2012. Following an extensive search process, the Company is pleased to announce that Richard Barham has been appointed Sales and Marketing Director and member of the Xaar board with effect from 5 March 2012. After completion of a handover period, Phil Eaves will continue to support the Company in a consultant role until 30 June 2012.

 

Ian Dinwoodie, Chief Executive commented:

 

'On behalf of everyone at Xaar, I would like to thank Phil for his efforts and contribution over the last 7 years during which our revenues have grown significantly. We all wish him well for the future.

 

I am pleased to welcome Richard to the Board, who brings a wealth of experience gained through 25 years spent in numerous sectors of the Imaging and Printing industries.'

Since 1986, Mr Barham has held a range of sales, marketing and management positions at Agfa Graphics NV, where most recently, since February 2008, he acted as Vice President of the Inkjet Division where he was responsible for turning the business around and integrating a major acquisition.

 

There is no further information concerning Mr Barham which requires disclosure under rule 9.6.13 of the UK Listing Authority Listing Rules.

 

 

END

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFFLFFFBBB
Date   Source Headline
13th Mar 20094:35 pmRNSPrice Monitoring Extension
6th Mar 20099:00 amRNSHolding(s) in Company
4th Mar 20097:00 amRNSNotice of Final Results
24th Feb 20097:00 amRNSNew product launch
18th Feb 200912:15 pmRNSDirector/PDMR Shareholding
16th Jan 20093:45 pmRNSHolding(s) in Company
15th Jan 20097:00 amRNSFull Year Trading Update
14th Jan 20093:00 pmRNSHolding(s) in Company
7th Jan 20094:15 pmRNSHolding(s) in Company
7th Jan 20099:00 amRNSHolding(s) in Company
23rd Dec 20083:57 pmRNSHolding(s) in Company
16th Dec 20084:40 pmRNSSecond Price Monitoring Extn
16th Dec 20084:35 pmRNSPrice Monitoring Extension
1st Dec 20083:10 pmRNSDirector/PDMR Shareholding
28th Nov 20089:00 amRNSDirector/PDMR Shareholding
26th Nov 20087:00 amRNSTrading Update
24th Nov 20084:40 pmRNSPrice Monitoring Extension
12th Nov 20084:05 pmRNSDirector/PDMR Shareholding Replacement
12th Nov 20083:03 pmRNSDirector/PDMR Shareholding
21st Oct 20089:00 amRNSHolding(s) in Company
15th Oct 20087:00 amRNSInterim Management Statement
13th Oct 20084:41 pmRNSSecond Price Monitoring Extn
13th Oct 20084:36 pmRNSPrice Monitoring Extension
30th Sep 20087:00 amRNSNotice of IMS
5th Sep 200810:00 amRNSBlocklisting Interim Review -
5th Sep 20089:08 amRNSBlocklisting Interim Review
4th Sep 20089:00 amRNSHolding(s) in Company
3rd Sep 20084:14 pmRNSDirector/PDMR Shareholding
28th Aug 200810:27 amRNSDirector/PDMR Shareholding
20th Aug 20087:00 amRNSHalf Yearly Report and Result
6th Aug 20087:00 amRNSNotice of Half Year Report
29th Jul 20089:39 amRNSHolding(s) in Company
25th Jul 20081:46 pmRNSHolding(s) in Company
15th Jul 200810:46 amRNSHolding(s) in Company
11th Jul 20087:00 amRNSPeriod end update & new broke
5th Jun 20086:00 pmRNSTotal Voting Rights
30th May 20087:00 amRNSAnalyst/investor visit to Dru
23rd May 20087:00 amRNSChina business update: recent
15th May 20082:49 pmRNSHolding(s) in Company
14th May 200810:10 amRNSDirectorate Change
13th May 200812:04 pmRNSResult of AGM
13th May 200812:04 pmRNSResult of AGM
13th May 20086:00 amRNSInterim Management & AGM Stat
9th May 200811:48 amRNSTotal Voting Rights
29th Apr 20082:23 pmRNSDirector/PDMR Shareholding
28th Apr 20084:35 pmRNSHolding(s) in Company
28th Apr 20087:00 amRNSDrupa exhibition preview
10th Apr 20083:50 pmRNSAnnual Information Update
2nd Apr 20085:43 pmRNSTotal Voting Rights
27th Mar 20086:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.